{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Tucson&page=23&state=Arizona", "query": { "state": "Arizona", "city": "Tucson", "page": 23 }, "page_size": 10 }, "pagination": { "page": 23, "page_size": 10, "total_count": 5390, "total_pages": 539, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Tucson&page=24&state=Arizona&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Tucson&page=22&state=Arizona&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-27T19:30:50.216Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02089334", "title": "Dose-Finding, Safety and Efficacy Study of RX-0201 Plus Everolimus in Metastatic Renal Cell Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Metastatic Renal Cell Cancer" ], "interventions": [ { "name": "RX-0201", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rexahn Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2014-08", "completion_date": "2018-05-17", "has_results": true, "last_update_posted_date": "2020-06-30", "last_synced_at": "2026-10-27T19:30:50.216Z", "location_count": 7, "location_summary": "Tucson, Arizona • Duarte, California • Albuquerque, New Mexico + 4 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "Albuquerque", "state": "New Mexico" }, { "city": "New York", "state": "New York" }, { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02089334" }, { "nct_id": "NCT05521698", "title": "A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Non-Muscle Invasive Bladder Urothelial Carcinoma", "Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma" ], "interventions": [ { "name": "Bicalutamide", "type": "DRUG" }, { "name": "Biopsy Procedure", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Transurethral Resection of Bladder Tumor", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE", "OTHER" ], "sponsor": "University of Wisconsin, Madison", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 80, "start_date": "2026-06-25", "completion_date": "2028-12-01", "has_results": false, "last_update_posted_date": "2026-09-30", "last_synced_at": "2026-10-27T19:30:50.216Z", "location_count": 6, "location_summary": "Tucson, Arizona • Los Angeles, California • Bethesda, Maryland + 3 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Bethesda", "state": "Maryland" }, { "city": "Rochester", "state": "New York" }, { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05521698" }, { "nct_id": "NCT02298192", "title": "A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetes", "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "insulin degludec/liraglutide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 420, "start_date": "2014-11-21", "completion_date": "2015-12-23", "has_results": true, "last_update_posted_date": "2017-05-23", "last_synced_at": "2026-10-27T19:30:50.216Z", "location_count": 40, "location_summary": "Hamilton, Alabama • Chandler, Arizona • Glendale, Arizona + 34 more", "locations": [ { "city": "Hamilton", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02298192" }, { "nct_id": "NCT01818336", "title": "Evaluation of Skin Testing Reagents for Penicillin Allergy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "History of IgE Dependent Reaction to a Penicillin Product" ], "interventions": [ { "name": "Penicillin skin test kit", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AllerQuest LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 481, "start_date": "2012-12", "completion_date": "2013-06", "has_results": true, "last_update_posted_date": "2017-01-04", "last_synced_at": "2026-10-27T19:30:50.216Z", "location_count": 13, "location_summary": "Homewood, Alabama • Tucson, Arizona • Walnut Creek, California + 10 more", "locations": [ { "city": "Homewood", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Norwalk", "state": "Connecticut" }, { "city": "West Hartford", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT01818336" }, { "nct_id": "NCT00760344", "title": "Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes Mellitus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetes Mellitus" ], "interventions": [ { "name": "SYR-472", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Sitagliptin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 386, "start_date": "2007-03", "completion_date": "2008-03", "has_results": false, "last_update_posted_date": "2016-06-22", "last_synced_at": "2026-10-27T19:30:50.216Z", "location_count": 105, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Montgomery, Alabama + 102 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00760344" }, { "nct_id": "NCT02680756", "title": "Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Anemia, Iron-Deficiency", "Inflammatory Bowel Disease", "Crohn's Disease" ], "interventions": [ { "name": "Ferric Maltol", "type": "DRUG" }, { "name": "Ferric Carboxy Maltose", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shield Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 250, "start_date": "2016-01", "completion_date": "2019-01", "has_results": true, "last_update_posted_date": "2020-11-02", "last_synced_at": "2026-10-27T19:30:50.216Z", "location_count": 17, "location_summary": "Dothan, Alabama • Tucson, Arizona • Gainesville, Florida + 14 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Hollywood", "state": "Florida" }, { "city": "Chevy Chase", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02680756" }, { "nct_id": "NCT00003139", "title": "Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Head and Neck Cancer", "Oral Complications" ], "interventions": [ { "name": "pilocarpine hydrochloride", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Radiation Therapy Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 249, "start_date": "1998-03", "completion_date": "2002-10", "has_results": false, "last_update_posted_date": "2015-11-17", "last_synced_at": "2026-10-27T19:30:50.216Z", "location_count": 216, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 166 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00003139" }, { "nct_id": "NCT07136012", "title": "OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cardiovascular Disease" ], "interventions": [ { "name": "Olpasiran", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "105 Years", "sex": "ALL", "summary": "50 Years to 105 Years" }, "enrollment_count": 11000, "start_date": "2025-08-22", "completion_date": "2031-10-20", "has_results": false, "last_update_posted_date": "2026-08-21", "last_synced_at": "2026-10-27T19:30:50.216Z", "location_count": 205, "location_summary": "Alexander City, Alabama • Birmingham, Alabama • Daphne, Alabama + 170 more", "locations": [ { "city": "Alexander City", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Daphne", "state": "Alabama" }, { "city": "Fairhope", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT07136012" }, { "nct_id": "NCT05319730", "title": "A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Esophageal Squamous Cell Carcinoma" ], "interventions": [ { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Irinotecan", "type": "DRUG" }, { "name": "Pembrolizumab", "type": "BIOLOGICAL" }, { "name": "MK-4830", "type": "BIOLOGICAL" }, { "name": "Lenvatinib", "type": "DRUG" }, { "name": "Sacituzumab tirumotecan", "type": "BIOLOGICAL" }, { "name": "Antihistamine", "type": "DRUG" }, { "name": "H2 Receptor Antagonist", "type": "DRUG" }, { "name": "Acetaminophen (or equivalent)", "type": "DRUG" }, { "name": "Dexamethasone (or equivalent)", "type": "DRUG" }, { "name": "Steroid Mouthwash (dexamethasone or equivalent)", "type": "DRUG" }, { "name": "Supportive care measures", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 230, "start_date": "2023-05-16", "completion_date": "2029-04-10", "has_results": false, "last_update_posted_date": "2026-10-07", "last_synced_at": "2026-10-27T19:30:50.216Z", "location_count": 5, "location_summary": "Tucson, Arizona • Los Angeles, California • East Syracuse, New York + 2 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "East Syracuse", "state": "New York" }, { "city": "New York", "state": "New York" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05319730" }, { "nct_id": "NCT03492281", "title": "A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Overactive Bladder" ], "interventions": [ { "name": "vibegron", "type": "DRUG" }, { "name": "Vibegron placebo", "type": "DRUG" }, { "name": "Tolterodine Tartrate ER", "type": "DRUG" }, { "name": "Tolterodine placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Urovant Sciences GmbH", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1530, "start_date": "2018-03-26", "completion_date": "2019-02-04", "has_results": true, "last_update_posted_date": "2021-03-04", "last_synced_at": "2026-10-27T19:30:50.216Z", "location_count": 191, "location_summary": "Birmingham, Alabama • Gulf Shores, Alabama • Huntsville, Alabama + 155 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Gulf Shores", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT03492281" } ] }